臨床薬理の進歩 No.46
112/216

6)Ogino T, Sekido Y, Hata T, Miyoshi N, Takahashi H, Uemura M, et al. The safety and feasibility of laparoscopic redo surgery for recurrent crohn’s disease: A comparative clinical study of over 100 consecutive patients. Ann Gastroenterol Surg 2021; 6(3): 405-11.7)Ogino T, Nishimura J, Barman S, Kayama H, Uematsu S, Okuzaki D, et al. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease. Gastroenterology 2013; 145(6): 1380-91.8)Barman S, Kayama H, Okuzaki D, Ogino T, Osawa H, Matsuno H, et al. Identification of a human intestinal myeloid cell subset that regulates gut homeostasis. Int Immunol 2016; 28(11): 533-45.9)Matsuno H, Kayama H, Nishimura J, Sekido Y, Osawa H, Barman S, et al. CD103+ dendritic cell function is altered in the colons of patients with ulcerative colitis. Inflammation Bowel Dis 2017; 23(9): 1524-34.文  献981)Ogino T, Mizushima T, Matsuda C, Mori M, Doki Y. Essential updates 2018/2019: Colorectal (benign): Recent updates (2018-2019) in the surgical treatment of benign colorectal diseases. Ann Gastroenterol Surg 2019; 4(1): 30-8. 2)Proposed guidelines for the management of patients with Crohn’s disease. Annual reports of Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labor and Welfare of Japan. 2008. (in Japanese).3)Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39(2): 207-11.4)Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 2009; 461(7264): 654-8.5)Kang YH, Cho M, Kim J, Kwon M, Peak J, Kang SW, et al. Impaired macrophage autophagy induces systemic insulin resistance in obesity. Oncotarget 2016; 7(24): 35577-91.

元のページ  ../index.html#112

このブックを見る